Nurix Therapeutics, Inc. NRIX
15.30 USD +0.46 (+3.10%)
At closeNov 6, 2026, 5:55 PM EST
15.07 -0.23 -1.50%
After hours · Nov 6, 5:55 PM ET
14.79 Day range 15.52
12.17 52-week range 27.79
- YTD
- -19.35%
- 1 year
- +22.20%
Revenue & Expenses
Latest period ending Nov 30, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Nov 30, 2025 | FY 2024 Nov 30, 2024 | FY 2023 Nov 30, 2023 | FY 2022 Nov 30, 2022 | FY 2021 Nov 30, 2021 |
|---|---|---|---|---|---|
| 83.98M | 54.55M | 76.99M | 38.63M | 29.75M | |
| 83.98M | 54.55M | 76.99M | 38.63M | 29.75M | |
| -285.67M | -213.03M | -155.06M | -183.87M | -117.89M | |
| -264.46M | -193.57M | -143.95M | -180.36M | -117.19M | |
| -3.05 | -2.88 | -2.65 | -3.71 | -2.73 |
Balance sheet
| Fiscal year | FY 2025 Nov 30, 2025 | FY 2024 Nov 30, 2024 | FY 2023 Nov 30, 2023 | FY 2022 Nov 30, 2022 | FY 2021 Nov 30, 2021 |
|---|---|---|---|---|---|
| 247.93M | 110.90M | 55.53M | 65.38M | 80.79M | |
| 688.13M | 669.34M | 355.60M | 416.76M | 476.77M | |
| 149.39M | 142.35M | 155.10M | 113.06M | 134.47M | |
| 55.73M | 28.30M | 30.61M | 11.96M | 13.04M | |
| 538.75M | 526.99M | 200.49M | 303.70M | 342.30M |
Cash flow
| Fiscal year | FY 2025 Nov 30, 2025 | FY 2024 Nov 30, 2024 | FY 2023 Nov 30, 2023 | FY 2022 Nov 30, 2022 | FY 2021 Nov 30, 2021 |
|---|---|---|---|---|---|
| -249.47M | -172.58M | -81.36M | -159.81M | -84.36M | |
| 147.85M | -257.71M | 68.30M | 27.20M | -108.25M | |
| 238.64M | 485.67M | 3.22M | 117.19M | 153.88M | |
| -14.00M | -9.27M | -8.40M | -12.24M | -5.66M | |
| 137.03M | 55.37M | -9.85M | -15.42M | -38.73M |